2020 – Page 23 – Policy & Medicine

FDA Draft Guidance on Drug Development Tools

Academic Medicine Article Calls to Eliminate EHR Vendors as Accredited CME Sponsors

NY State Overbilled Medicaid Almost $40 Million for Opioid Treatment Programs

Healthcare Providers Have Gloomy Outlook About Financing Healthcare

FDA Releases Draft Guidance on Biosimilar Review

FDA and FTC Join Forces on Biosimilar Marketing

Telemedicine Company Owners Charged with Conspiracy

FDA and NIH Don’t Always Enforce Clinical Trial Transparency Regulations

John Kamp Inducted into the Medical Advertising Hall of Fame

Blue Cross Blue Shield Invests in Nonprofit Aimed at Cheaper Drugs